Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

AKTS

Aktis Oncology Inc

May 29 • 04:00PM ET

20.74

+0.31 1.52 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: IDYA RCUS TNGX CGON KYMR NUVL BMRN RYTM INCY KRYS

| Held by: VTI IWM VXF VTWO SCHA IWO IWN ITOT SCHB IWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-	Insider Own	42.48%	Shs Outstand	53.40M	Perf Week	8.47%
Market Cap	1.15B	Forward P/E	-	EPS next Y	-2.31	Insider Trans	37.07%	Shs Float	31.79M	Perf Month	10.79%
Enterprise Value	619.61M	PEG	-	EPS next Q	-0.44	Inst Own	45.93%	Short Float	7.95%	Perf Quarter	3.03%
Income	-	P/S	-	EPS this Y	97.91%	Inst Trans	85.43%	Short Ratio	7.91	Perf Half Y	-
Sales	-	P/B	2.27	EPS next Y	-40.77%	ROA	-	Short Interest	2.53M	Perf YTD	-7.41%
Book/sh	9.16	P/C	2.13	EPS next 5Y	64.24%	ROE	-	52W High	29.16 -28.88%	Perf Year	-
Cash/sh	9.74	P/FCF	-	EPS past 3/5Y	-47.94% -	ROIC	-	52W Low	14.72 40.90%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.65% 5.96%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.18	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	19.49	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	58.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	19.49	EPS Q/Q	-	SMA20	6.58%	Beta	-	Target Price	32.50
Payout	-	Debt/Eq	0.02	Sales Q/Q	-	SMA50	10.14%	Rel Volume	0.44	Prev Close	20.43
Employees	79	LT Debt/Eq	0.02	Earnings	May 11 AMC	SMA200	7.55%	Avg Volume	319.40K	Price	20.74
IPO	Jan 09, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	-4.23% 67.20%	Trades		Volume	141,975	Change	1.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)